69 Conformationally restricted analogs of a new class of potent non-nucleoside reverse transcriptase inhibitors: R. Noreen 1, P. Engelhardt 1, J. Kangametsa 1, C. Sahlberg 1, L. Vrang 1, J. M. Morin, Jr. 2, R. J. Ternansky 2, and H. Zhang 1. 1Medivir AB, Huddinge, Sweden; 2Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

doi:10.1016/0166-3542(93)90447-q

69 Conformationally restricted analogs of a new class of potent non-nucleoside reverse transcriptase inhibitors: R. Noreen 1, P. Engelhardt 1, J. Kangametsa 1, C. Sahlberg 1, L. Vrang 1, J. M. Morin, Jr. 2, R. J. Ternansky 2, and H. Zhang 1. 1Medivir AB, Huddinge, Sweden; 2Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

https://doi.org/10.1016/0166-3542(93)90447-q

Copy DOI

Journal: Antiviral research

Publication Date: Apr 1, 1993

#Potent Non-nucleoside Reverse Transcriptase Inhibitors #Analogs Of Class + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

69 Conformationally restricted analogs of a new class of potent non-nucleoside reverse transcriptase inhibitors: R. Noreen 1, P. Engelhardt 1, J. Kangametsa 1, C. Sahlberg 1, L. Vrang 1, J. M. Morin, Jr. 2, R. J. Ternansky 2, and H. Zhang 1. 1Medivir AB, Huddinge, Sweden; 2Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

Full Text